Terms: = Breast cancer AND CBFB, PEBP2B, 865, ENSG00000067955, Q13951 AND Treatment
51 results:
1. [Identification of breast cancer subtypes based on graph convolutional network].
An Y; Liu X; Chen H; Wan G
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2024 Feb; 41(1):121-128. PubMed ID: 38403612
[TBL] [Abstract] [Full Text] [Related]
2. Psychometric evaluation of the Chinese version of the breast cancer perception scale for community women: a translation and validation study.
Kong L; Yang Z; Zheng C; Lu T; Zhang H
Breast Cancer; 2024 Jan; 31(1):42-52. PubMed ID: 37828267
[TBL] [Abstract] [Full Text] [Related]
3. Deep learning radiopathomics based on preoperative US images and biopsy whole slide images can distinguish between luminal and non-luminal tumors in early-stage breast cancers.
Huang Y; Yao Z; Li L; Mao R; Huang W; Hu Z; Hu Y; Wang Y; Guo R; Tang X; Yang L; Wang Y; Luo R; Yu J; Zhou J
EBioMedicine; 2023 Aug; 94():104706. PubMed ID: 37478528
[TBL] [Abstract] [Full Text] [Related]
4. The mutational landscape of a US Midwestern breast cancer cohort reveals subtype-specific cancer drivers and prognostic markers.
Vellichirammal NN; Tan YD; Xiao P; Eudy J; Shats O; Kelly D; Desler M; Cowan K; Guda C
Hum Genomics; 2023 Jul; 17(1):64. PubMed ID: 37454130
[TBL] [Abstract] [Full Text] [Related]
5. Risk Factors for Infusion Reactions in Patients with breast cancer Administered Trastuzumab Therapy.
Tabuchi Y; Tsujimoto M; Yamamoto K; Shimizu R; Kosaka T; Sakaguchi K; Dobuchi N; Nishiguchi K; Shikata K
Biol Pharm Bull; 2023; 46(7):964-968. PubMed ID: 37394646
[TBL] [Abstract] [Full Text] [Related]
6. Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic cancer.
Tsimberidou AM; Guenther K; Andersson BS; Mendrzyk R; Alpert A; Wagner C; Nowak A; Aslan K; Satelli A; Richter F; Kuttruff-Coqui S; Schoor O; Fritsche J; Coughlin Z; Mohamed AS; Sieger K; Norris B; Ort R; Beck J; Vo HH; Hoffgaard F; Ruh M; Backert L; Wistuba II; Fuhrmann D; Ibrahim NK; Morris VK; Kee BK; Halperin DM; Nogueras-Gonzalez GM; Kebriaei P; Shpall EJ; Vining D; Hwu P; Singh H; Reinhardt C; Britten CM; Hilf N; Weinschenk T; Maurer D; Walter S
Cancer Immunol Res; 2023 Jul; 11(7):925-945. PubMed ID: 37172100
[TBL] [Abstract] [Full Text] [Related]
7. Profiling the Somatic Mutational Landscape of breast Tumors from Hispanic/Latina Women Reveals Conserved and Unique Characteristics.
Ding YC; Song H; Adamson AW; Schmolze D; Hu D; Huntsman S; Steele L; Patrick CS; Tao S; Hernandez N; Adams CD; Fejerman L; Gardner K; Nápoles AM; Pérez-Stable EJ; Weitzel JN; Bengtsson H; Huang FW; Neuhausen SL; Ziv E
Cancer Res; 2023 Aug; 83(15):2600-2613. PubMed ID: 37145128
[TBL] [Abstract] [Full Text] [Related]
8. The Preoperative Serum Levels of the Anaphylatoxins C3a and C5a and Their Association with Clinico-Pathological Factors in breast cancer Patients.
Hameed BH; Abdulsatar Al-Rayahi I; Muhsin SS
Arch Razi Inst; 2022 Oct; 77(5):1873-1879. PubMed ID: 37123148
[TBL] [Abstract] [Full Text] [Related]
9. Dysregulation of Mitochondrial Translation Caused by cbfb Deficiency Cooperates with Mutant PIK3CA and Is a Vulnerability in breast cancer.
Malik N; Kim YI; Yan H; Tseng YC; du Bois W; Ayaz G; Tran AD; Vera-Ramirez L; Yang H; Michalowski AM; Kruhlak M; Lee M; Hunter KW; Huang J
Cancer Res; 2023 Apr; 83(8):1280-1298. PubMed ID: 36799863
[TBL] [Abstract] [Full Text] [Related]
10. Does concurrent gynaecological surgery affect infectious complications rate after mastectomy with implant-based reconstruction?
Pislar N; Peric B; Ahcan U; Cencelj-Arnez R; Zgajnar J; Perhavec A
Radiol Oncol; 2023 Mar; 57(1):80-85. PubMed ID: 35853741
[TBL] [Abstract] [Full Text] [Related]
11. A 10-miRNA risk score-based prediction model for pathological complete response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer.
Gong C; Cheng Z; Yang Y; Shen J; Zhu Y; Ling L; Lin W; Yu Z; Li Z; Tan W; Zheng C; Zheng W; Zhong J; Zhang X; Zeng Y; Liu Q; Huang RS; Komorowski AL; Yang ES; Bertucci F; Ricci F; Orlandi A; Franceschini G; Takabe K; Klimberg S; Ishii N; Toss A; Tan MP; Cherian MA; Song E
Sci China Life Sci; 2022 Nov; 65(11):2205-2217. PubMed ID: 35579777
[TBL] [Abstract] [Full Text] [Related]
12. Development of a Prognostic App (iCanPredict) to Predict Survival for Chinese Women With breast cancer: Retrospective Study.
Ma Z; Huang S; Wu X; Huang Y; Chan SW; Lin Y; Zheng X; Zhu J
J Med Internet Res; 2022 Mar; 24(3):e35768. PubMed ID: 35262503
[TBL] [Abstract] [Full Text] [Related]
13. Radiomics model based on shear-wave elastography in the assessment of axillary lymph node status in early-stage breast cancer.
Jiang M; Li CL; Luo XM; Chuan ZR; Chen RX; Tang SC; Lv WZ; Cui XW; Dietrich CF
Eur Radiol; 2022 Apr; 32(4):2313-2325. PubMed ID: 34671832
[TBL] [Abstract] [Full Text] [Related]
14. Symptom status, body perception, and risk of anxiety and depression in breast cancer patients receiving paclitaxel: a prospective longitudinal study.
Gokce Ceylan G; Gok Metin Z
Support Care Cancer; 2022 Mar; 30(3):2069-2079. PubMed ID: 34657181
[TBL] [Abstract] [Full Text] [Related]
15. Patterns of genomic change in residual disease after neoadjuvant chemotherapy for estrogen receptor-positive and HER2-negative breast cancer.
Chatzipli A; Bonnefoi H; MacGrogan G; Sentis J; Cameron D; Poncet C; ; Iggo R
Br J Cancer; 2021 Nov; 125(10):1356-1364. PubMed ID: 34480095
[TBL] [Abstract] [Full Text] [Related]
16. Higher Risk of Depression After Total Mastectomy Versus breast Reconstruction Among Adult Women With breast cancer: A Systematic Review and Metaregression.
Padmalatha S; Tsai YT; Ku HC; Wu YL; Yu T; Fang SY; Ko NY
Clin Breast Cancer; 2021 Oct; 21(5):e526-e538. PubMed ID: 33541834
[TBL] [Abstract] [Full Text] [Related]
17. Diagnostic value of cfDNA and long fragment DNA in patients with breast cancer.
Xu H; Liu G
Cell Mol Biol (Noisy-le-grand); 2020 Oct; 66(7):186-189. PubMed ID: 33287940
[TBL] [Abstract] [Full Text] [Related]
18. The transcription factor cbfb mutations indicate an improved survival in HR+/HER2- breast cancer.
Guo L; Chen B; Zhang G; Wang Y; Cao L; Ren C; Wen L; Lin J; Wei G; Liao N
Gene; 2020 Oct; 759():144970. PubMed ID: 32711101
[TBL] [Abstract] [Full Text] [Related]
19. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.
Liu J; Prager-van der Smissen WJC; Collée JM; Bolla MK; Wang Q; Michailidou K; Dennis J; Ahearn TU; Aittomäki K; Ambrosone CB; Andrulis IL; Anton-Culver H; Antonenkova NN; Arndt V; Arnold N; Aronson KJ; Augustinsson A; Auvinen P; Becher H; Beckmann MW; Behrens S; Bermisheva M; Bernstein L; Bogdanova NV; Bogdanova-Markov N; Bojesen SE; Brauch H; Brenner H; Briceno I; Brucker SY; Brüning T; Burwinkel B; Cai Q; Cai H; Campa D; Canzian F; Castelao JE; Chang-Claude J; Chanock SJ; Choi JY; Christiaens M; Clarke CL; ; Couch FJ; Czene K; Daly MB; Devilee P; Dos-Santos-Silva I; Dwek M; Eccles DM; Eliassen AH; Fasching PA; Figueroa J; Flyger H; Fritschi L; Gago-Dominguez M; Gapstur SM; García-Closas M; García-Sáenz JA; Gaudet MM; Giles GG; Goldberg MS; Goldgar DE; Guénel P; Haiman CA; Håkansson N; Hall P; Harrington PA; Hart SN; Hartman M; Hillemanns P; Hopper JL; Hou MF; Hunter DJ; Huo D; ; Ito H; Iwasaki M; Jakimovska M; Jakubowska A; John EM; Kaaks R; Kang D; Keeman R; Khusnutdinova E; Kim SW; Kraft P; Kristensen VN; Kurian AW; Le Marchand L; Li J; Lindblom A; Lophatananon A; Luben RN; Lubiński J; Mannermaa A; Manoochehri M; Manoukian S; Margolin S; Mariapun S; Matsuo K; Maurer T; Mavroudis D; Meindl A; Menon U; Milne RL; Muir K; Mulligan AM; Neuhausen SL; Nevanlinna H; Offit K; Olopade OI; Olson JE; Olsson H; Orr N; Park SK; Peterlongo P; Peto J; Plaseska-Karanfilska D; Presneau N; Rack B; Rau-Murthy R; Rennert G; Rennert HS; Rhenius V; Romero A; Ruebner M; Saloustros E; Schmutzler RK; Schneeweiss A; Scott C; Shah M; Shen CY; Shu XO; Simard J; Sohn C; Southey MC; Spinelli JJ; Tamimi RM; Tapper WJ; Teo SH; Terry MB; Torres D; Truong T; Untch M; Vachon CM; van Asperen CJ; Wolk A; Yamaji T; Zheng W; Ziogas A; Ziv E; Torres-Mejía G; Dörk T; Swerdlow AJ; Hamann U; Schmidt MK; Dunning AM; Pharoah PDP; Easton DF; Hooning MJ; Martens JWM; Hollestelle A
Sci Rep; 2020 Jun; 10(1):9688. PubMed ID: 32546843
[TBL] [Abstract] [Full Text] [Related]
20. Novel breast cancer screening: combined expression of miR-21 and MMP-1 in urinary exosomes detects 95% of breast cancer without metastasis.
Ando W; Kikuchi K; Uematsu T; Yokomori H; Takaki T; Sogabe M; Kohgo Y; Otori K; Ishikawa S; Okazaki I
Sci Rep; 2019 Sep; 9(1):13595. PubMed ID: 31537868
[TBL] [Abstract] [Full Text] [Related]
[Next]
